Mick Mulvaney hinted at a strategy to combat high drug prices for those insured through Medicare this week while attending a Stanford University conference. The strategy would involve drug makers paying a mandatory Medicare rebate off a drug’s list price. This would help lower the cost of drugs to the prices of Medicaid drugs, which are already rebated. The Trump administration has focused on drug prices since President’ Trump’s inauguration in January. Read the full article here.